|Articles|March 5, 2018
Jamie Macdonald Appointed as the New CEO of PAREXEL
Advertisement
PAREXEL International Corporation announced the appointment of Jamie Macdonald as CEO effective March 15, 2018. The current CEO and co-founder of the company, Josef von Rickenbach will retire from his daily duties and continue as Chairman of the Board.
Read the full release
here
.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
3
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
4
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
